Researchers are excited about the medication , a groundbreaking dual agonist showing significant data in initial trials for weight loss . It functions by modulating two pathways : GLP-1 and GIP, which , https://nelsonaeiy878716.blogprodesign.com/62163329/this-new-prospect-for-body-loss